Montelukast Prescribing at ROYAL PRIMARY CARE BROOKLYN
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,068
Total Quantity
40.2K
NHS Cost
£1.9K
vs National Avg
+56%
ROYAL PRIMARY CARE BROOKLYN prescribed 1,068 items of Montelukast over the last 12 months at a cost of £1,939 to the NHS. This is 56% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
85
Jul 2026
86
Jul 2026
101
Jul 2026
84
Jul 2026
89
Jul 2026
95
Jul 2026
88
Jul 2026
90
Jul 2026
95
Jul 2026
83
Jul 2026
84
Jul 2026
88
Prescribing Details
| Total Items | 1,068 |
|---|---|
| Total Quantity | 40,180 |
| Total NHS Cost | £1,939 |
| Presentations | 4 different forms |
| vs National Average | +56% |
Montelukast Prescribing Comparison
| This practice | 1,068 items |
|---|---|
| National average per practice | 685 items |
| Difference | +56% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.